Valion Bio, Inc. (VBIO)
- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $0.54
- As of
Kresmion compiles this page from VBIO's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
Valion Bio, Inc. (VBIO): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-11-16.
See the full VBIO dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for VBIO on one page. Preview it with sample data, then open it live with a free account.
Preview the VBIO dossierActive events for VBIO
- medium13F: new position
CITADEL ADVISORS LLC new position in VBIO
- mediumEarnings above estimates
Q4-2022: Beat consensus by 27.5% - EPS $-289 vs $-398.82 estimate
- mediumEarnings above estimates
Q2-2023: Beat consensus by 14.2% - EPS $-119 vs $-138.72 estimate
- mediumEarnings above estimates
Q3-2023: Beat consensus by 79.3% - EPS $-25.16 vs $-121.38 estimate
- mediumEarnings above estimates
Q2-2024: Beat consensus by 94.8% - EPS $-0.32 vs $-6.12 estimate
FREE, NO ACCOUNT
Every event on VBIO, as it fires
You are seeing 5 of 9 events recorded on VBIO since 2026-05-26.
The five above landed across 2 days. The other 4 were recorded on 1 other days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter. Other reporting quarters are linked above.
Recent SEC filings, VBIO
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
Going concern statement
VBIO's 10-Q filed Aug 14, 2026 states:
The aforementioned factors raise substantial doubt about the Company's ability to continue as a going concern within one year from the issuance date of the consolidated financial statements.
Read the 10-Q on SEC EDGAR Every company with a going concern statement
More data on VBIO
Cite this data
Kresmion counts the managers it follows that reported a non-option position in VBIO on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on VBIO in the last 180 days.
Upstream: SEC EDGAR filings for VBIO
Kresmion, "Valion Bio, Inc. (VBIO) institutional holdings and SEC filings", data as of 2026-11-16, https://kresmion.com/research/VBIO. Upstream data: SEC EDGAR filings for VBIO.
Link to this data (HTML):
<a href="https://kresmion.com/research/VBIO">Valion Bio, Inc. (VBIO) institutional holdings and SEC filings (Kresmion)</a>
Writing about this? Press contact and ready-to-quote figures
Follow VBIO on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to VBIO for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.